Clinical Efficacy Analysis of Biofeedback Electrical Stimulation Combined with Doxycycline in the Treatment of Type IIIA Chronic Prostatitis

Author:

Sun Xiaoyong1,Lin Tangtang1,Fang Jinying1,Liu Jinming1,Yao Wenliang2,Geng Liguo3,Zhang Jinfeng4ORCID

Affiliation:

1. Department of Chinese Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi 341000, China

2. Department of Andrology, Nanchang Reproductive Hospital, Nanchang, Jiangxi 330000, China

3. Department of Andrology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Zhuhai Hospital, Zhuhai, Guangdong 519000, China

4. Department of Anorectal, Ganzhou Hospital of Traditional Chinese Medicine, Ganzhou, Jiangxi 341000, China

Abstract

Purpose. To analyse the clinical efficacy of biofeedback electrical stimulation combined with doxycycline in the treatment of type IIIA chronic prostatitis. Methods. Eighty patients who met the diagnostic criteria of type IIIA chronic prostatitis in our hospital between February 2020 and February 2022 were selected and equally divided into the drug group and electrical stimulation group according to the random number table method. The drug group was treated with medication alone for 4 weeks; the electrostimulation group was treated with biofeedback electrostimulation on top of medication for 12 weeks. The expressed prostatic secretious (EPS) routine (lecithin bodies, white blood cells) and the maximum urinary flow rate (Qmax) and mean urinary flow rate (Qave) were measured before and after treatment in both groups, and the National Institutes of Health chronic prostatitis symptom index (NIH-CPSI) was used to score the urinary symptom, pain or discomfort, and quality of life and determine the efficacy of the treatment in both groups. Results. After treatment, the number of lecithin bodies and white blood cells in EPS improved significantly in both groups compared to before, and both the electrical stimulation group was better than the drug group ( P < 0.05 ). After treatment, the Qmax and Qave were significantly higher in both groups than before, and both the electrical stimulation groups were higher than the drug group ( P < 0.05 ). After treatment, the urinary symptom scores, pain or discomfort scores, quality of life scores, and total NIH-CPSI scores were significantly lower in both groups than before, and all were lower in the electrical stimulation group than in the drug group ( P < 0.05 ). After treatment, the overall efficiency of patients in the electrical stimulation group was significantly higher than that of the drug group ( P < 0.05 ). Conclusion. Biofeedback electrical stimulation combined with doxycycline in the treatment of type IIIA chronic prostatitis can synergistically improve the patient’s inflammation level, urinary dysfunction, relieve pelvic floor tension myalgia, and improve their quality of life, opening up new avenues for the rehabilitation of patients with type IIIA chronic prostatitis.

Publisher

Hindawi Limited

Subject

Complementary and alternative medicine

Reference23 articles.

1. Boswellia resin extract and propolis derived polyphenols in patients with type III chronic prostatitis/chronic pelvic pain syndrome: an Italian prospective multicenter study;F. Presicce;Asian Journal of Urology,2022

2. Careful assessment key in managing prostatitis;R. Gujadhur;Practitioner,2015

3. International clinical practice guideline of Chinese medicine anxiety;Q. S. Tang;World Journal of Traditional Chinese Medicine,2021

4. Recent Advances in the Development of Noble Metal NPs for Cancer Therapy

5. Recent Advances in Pharmacological Interventions of Chronic Prostatitis/ Chronic Pelvic Pain Syndrome

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3